BOTTI, ELISABETTA
BOTTI, ELISABETTA
Dipartimento di Medicina dei sistemi
A regulatory feedback loop involving p63 and IRF6 links the pathogenesis of 2 genetically different human ectodermal dysplasias
2010-05-03 Moretti, F; Marinari, B; Lo Iacono, N; Botti, E; Giunta, A; Spallone, G; Garaffo, G; Vernersson Lindahl, E; Merlo, G; Mills, A; Ballarò, C; Alemà, S; Chimenti, S; Guerrini, L; Costanzo, A
Allele-specific cytokine responses at the HLA-C locus: Implications for psoriasis
2012-01-01 Hundhausen, C; Bertoni, A; Mak, Rk; Botti, E; Di Meglio, P; Clop, A; Laggner, U; Chimenti, S; Hayday, Ac; Barker, Jn; Trembath, Rc; Capon, F; Nestle, Fo
Anti-LL37 antibodies are present in psoriatic arthritis (PsA) patients: New biomarkers in PsA
2018-01-01 Frasca, L; Palazzo, R; Chimenti, Ms; Alivernini, S; Tolusso, B; Bui, L; Botti, E; Giunta, A; Bianchi, L; Petricca, L; Auteri, Se; Spadaro, F; Fonti, Gl; Falchi, M; Evangelista, A; Marinari, B; Pietraforte, I; Spinelli, Fr; Colasanti, T; Alessandri, C; Conti, F; Gremese, E; Costanzo, A; Valesini, G; Perricone, R; Lande, R
Assessing the expression of HLA-Cw6 using specific single chain antibody (scFv)
2008-01-01 Botti, E; Hundhausen, C; Laggner, U; DI MEGLIO, P; Marget, M; Chimenti, S; Nestle, Fo
Bowel-associated dermatosis arthritis syndrome and palisading neutrophilic granulomatous dermatitis as presentation of ulcerative colitis
2019-03-29 Caposiena Caro, Rd; Di Prete, M; Didona, D; Botti, E; Orlandi, A; Bianchi, L
Clindamycin versus clindamycin plus rifampicin in Hidradenitis Suppurativa treatment: clinical and ultrasound observations
2019-01-01 Caposiena Caro, Rd; Cannizzaro, Mv; Botti, E; Di Raimondo, C; Di Matteo, E; Gaziano, R; Bianchi, L
Confocal, wide band spectral reflection microscope, and relevant spectral imaging method
2011-12-01 Romana Bertani, F; Botti, E; Cilloco, F; Costanzo, A; Ferrari, L; Selci, S
Cutaneous mastocytosis: a dermatological perspective
2020-10-11 Di Raimondo, C; Del Duca, E; Silvaggio, D; Di Prete, M; Lombardo, P; Mazzeo, M; Spallone, G; Campione, E; Botti, E; Bianchi, L
Cw6 but not allele LCE3C_LCE3B deletion confers sensitivity to ustekinumab treatment in psoriasis
2012-09-01 Botti, E; Talamonti, M; Spallone, G; Galluzzo, M; Bavetta, M; Teoli, M; Pinetti, V; Costanzo, A
CXCL4 assembles DNA into liquid crystalline complexes to amplify TLR9-mediated interferon-α production in systemic sclerosis
2019-01-01 Lande, R; Lee, Ey; Palazzo, R; Marinari, B; Pietraforte, I; Santos, Gs; Mattenberger, Y; Spadaro, F; Stefanantoni, K; Iannace, N; Dufour, Am; Falchi, M; Bianco, M; Botti, E; Bianchi, L; Alvarez, M; Riccieri, V; Truchetet, M; C L Wong, G; Chizzolini, C; Frasca, L
Detection of adalimumab and anti-adalimumab levels by ELISA: clinical considerations
2014-11-01 Marinari, B; Botti, E; Bavetta, M; Spallone, G; Zangrilli, A; Talamonti, M; Richetta, A; Chimenti, S; Costanzo, A
Developmental factor IRF6 exhibits tumor suppressor activity in squamous cell carcinomas
2011-01-01 Botti, E; Spallone, G; Moretti, F; Marinari, B; Pinetti, V; Galanti, S; De Meo, Pd; De Nicola, F; Ganci, F; Castrignano, T; Pesole, G; Chimenti, S; Guerrini, L; Fanciulli, M; Blandino, G; Karin, M; Costanzo, A
Dimethylfumarate efficacy and safety in palmoplantar psoriasis patient affected by hepatitis b and depression: A case report
2020-05-23 Mazzilli, S; Cosio, T; Botti, E; Petruzzellis, A; Lanna, C; Diluvio, L; Bianchi, L; Campione, E
Effects of topical methotrexate loaded gold nanoparticle in cutaneous inflammatory mouse model
2019-01-01 Fratoddi, I; Benassi, L; Botti, E; Vaschieri, C; Venditti, I; Bessar, H; Samir, Ma; Azzoni, P; Magnoni, C; Costanzo, A; Casagrande, V; Federici, M; Bianchi, L; Pellacani, G
Efficacy of efalizumab in psoriasis patients previously treated with tumour necrosis factor blockers
2009-01-01 Costanzo, A; Talamonti, M; Botti, E; Spallone, G; Papoutsaki, M; Chimenti, S
Efficacy of short-term cyclosporine treatment to control psoriasis-related events during efalizumab therapy
2009-01-01 Costanzo, A; Talamonti, M; Spallone, G; Botti, E; Chimenti, Ms; Papoutsaki, M; Chimenti, S
Etanercept reverses downregulation of inhibitor of nuclear factor kappa-B kinase subunit alpha (IKKa) in psoriasis
2013-01-01 Spallone, G; Botti, E; Pinetti, V; Bavetta, M; Pavlidis, A; Chimenti, S; Costanzo, A
Functionalized gold nanoparticles for topical delivery of methotrexate for the possible treatment of psoriasis
2016-01-01 Bessar, H; Venditti, I; Benassi, L; Vaschieri, C; Azzoni, P; Pellacani, G; Magnoni, C; Botti, E; Casagrande, V; Federici, M; Costanzo, A; Fontana, L; Testa, G; Mostafa, F; Ibrahim, S; Russo, M; Fratoddi, I
Genetic markers predictive of clinical response to biological drugs in psoriasis.
2015-12-01 Marinari, B; Talamonti, M; Costanzo, A; Botti, E
Genetic variati ons in IL6 and IL12B as protecti ve markers for psoriasis Abstracts of the 2013 International Investigative Dermatology Meeting. May 8-11, 2013. Edinburgh, Scotland, United Kingdom
2013-05-01 Boca, A; Talamonti, M; Galluzzo, M; Botti, E; Buzoianu, A; Costanzo., A
Data di pubblicazione | Titolo | Autore(i) | Tipo | File |
---|---|---|---|---|
3-mag-2010 | A regulatory feedback loop involving p63 and IRF6 links the pathogenesis of 2 genetically different human ectodermal dysplasias | Moretti, F; Marinari, B; Lo Iacono, N; Botti, E; Giunta, A; Spallone, G; Garaffo, G; Vernersson Lindahl, E; Merlo, G; Mills, A; Ballarò, C; Alemà, S; Chimenti, S; Guerrini, L; Costanzo, A | Articolo su rivista | |
1-gen-2012 | Allele-specific cytokine responses at the HLA-C locus: Implications for psoriasis | Hundhausen, C; Bertoni, A; Mak, Rk; Botti, E; Di Meglio, P; Clop, A; Laggner, U; Chimenti, S; Hayday, Ac; Barker, Jn; Trembath, Rc; Capon, F; Nestle, Fo | Articolo su rivista | |
1-gen-2018 | Anti-LL37 antibodies are present in psoriatic arthritis (PsA) patients: New biomarkers in PsA | Frasca, L; Palazzo, R; Chimenti, Ms; Alivernini, S; Tolusso, B; Bui, L; Botti, E; Giunta, A; Bianchi, L; Petricca, L; Auteri, Se; Spadaro, F; Fonti, Gl; Falchi, M; Evangelista, A; Marinari, B; Pietraforte, I; Spinelli, Fr; Colasanti, T; Alessandri, C; Conti, F; Gremese, E; Costanzo, A; Valesini, G; Perricone, R; Lande, R | Articolo su rivista | |
1-gen-2008 | Assessing the expression of HLA-Cw6 using specific single chain antibody (scFv) | Botti, E; Hundhausen, C; Laggner, U; DI MEGLIO, P; Marget, M; Chimenti, S; Nestle, Fo | Intervento a convegno | |
29-mar-2019 | Bowel-associated dermatosis arthritis syndrome and palisading neutrophilic granulomatous dermatitis as presentation of ulcerative colitis | Caposiena Caro, Rd; Di Prete, M; Didona, D; Botti, E; Orlandi, A; Bianchi, L | Articolo su rivista | |
1-gen-2019 | Clindamycin versus clindamycin plus rifampicin in Hidradenitis Suppurativa treatment: clinical and ultrasound observations | Caposiena Caro, Rd; Cannizzaro, Mv; Botti, E; Di Raimondo, C; Di Matteo, E; Gaziano, R; Bianchi, L | Articolo su rivista | |
1-dic-2011 | Confocal, wide band spectral reflection microscope, and relevant spectral imaging method | Romana Bertani, F; Botti, E; Cilloco, F; Costanzo, A; Ferrari, L; Selci, S | Brevetti | |
11-ott-2020 | Cutaneous mastocytosis: a dermatological perspective | Di Raimondo, C; Del Duca, E; Silvaggio, D; Di Prete, M; Lombardo, P; Mazzeo, M; Spallone, G; Campione, E; Botti, E; Bianchi, L | Articolo su rivista | |
1-set-2012 | Cw6 but not allele LCE3C_LCE3B deletion confers sensitivity to ustekinumab treatment in psoriasis | Botti, E; Talamonti, M; Spallone, G; Galluzzo, M; Bavetta, M; Teoli, M; Pinetti, V; Costanzo, A | Intervento a convegno | |
1-gen-2019 | CXCL4 assembles DNA into liquid crystalline complexes to amplify TLR9-mediated interferon-α production in systemic sclerosis | Lande, R; Lee, Ey; Palazzo, R; Marinari, B; Pietraforte, I; Santos, Gs; Mattenberger, Y; Spadaro, F; Stefanantoni, K; Iannace, N; Dufour, Am; Falchi, M; Bianco, M; Botti, E; Bianchi, L; Alvarez, M; Riccieri, V; Truchetet, M; C L Wong, G; Chizzolini, C; Frasca, L | Articolo su rivista | |
1-nov-2014 | Detection of adalimumab and anti-adalimumab levels by ELISA: clinical considerations | Marinari, B; Botti, E; Bavetta, M; Spallone, G; Zangrilli, A; Talamonti, M; Richetta, A; Chimenti, S; Costanzo, A | Articolo su rivista | |
1-gen-2011 | Developmental factor IRF6 exhibits tumor suppressor activity in squamous cell carcinomas | Botti, E; Spallone, G; Moretti, F; Marinari, B; Pinetti, V; Galanti, S; De Meo, Pd; De Nicola, F; Ganci, F; Castrignano, T; Pesole, G; Chimenti, S; Guerrini, L; Fanciulli, M; Blandino, G; Karin, M; Costanzo, A | Articolo su rivista | |
23-mag-2020 | Dimethylfumarate efficacy and safety in palmoplantar psoriasis patient affected by hepatitis b and depression: A case report | Mazzilli, S; Cosio, T; Botti, E; Petruzzellis, A; Lanna, C; Diluvio, L; Bianchi, L; Campione, E | Articolo su rivista | |
1-gen-2019 | Effects of topical methotrexate loaded gold nanoparticle in cutaneous inflammatory mouse model | Fratoddi, I; Benassi, L; Botti, E; Vaschieri, C; Venditti, I; Bessar, H; Samir, Ma; Azzoni, P; Magnoni, C; Costanzo, A; Casagrande, V; Federici, M; Bianchi, L; Pellacani, G | Articolo su rivista | |
1-gen-2009 | Efficacy of efalizumab in psoriasis patients previously treated with tumour necrosis factor blockers | Costanzo, A; Talamonti, M; Botti, E; Spallone, G; Papoutsaki, M; Chimenti, S | Articolo su rivista | |
1-gen-2009 | Efficacy of short-term cyclosporine treatment to control psoriasis-related events during efalizumab therapy | Costanzo, A; Talamonti, M; Spallone, G; Botti, E; Chimenti, Ms; Papoutsaki, M; Chimenti, S | Articolo su rivista | |
1-gen-2013 | Etanercept reverses downregulation of inhibitor of nuclear factor kappa-B kinase subunit alpha (IKKa) in psoriasis | Spallone, G; Botti, E; Pinetti, V; Bavetta, M; Pavlidis, A; Chimenti, S; Costanzo, A | Articolo su rivista | |
1-gen-2016 | Functionalized gold nanoparticles for topical delivery of methotrexate for the possible treatment of psoriasis | Bessar, H; Venditti, I; Benassi, L; Vaschieri, C; Azzoni, P; Pellacani, G; Magnoni, C; Botti, E; Casagrande, V; Federici, M; Costanzo, A; Fontana, L; Testa, G; Mostafa, F; Ibrahim, S; Russo, M; Fratoddi, I | Articolo su rivista | |
1-dic-2015 | Genetic markers predictive of clinical response to biological drugs in psoriasis. | Marinari, B; Talamonti, M; Costanzo, A; Botti, E | Brevetti | |
1-mag-2013 | Genetic variati ons in IL6 and IL12B as protecti ve markers for psoriasis Abstracts of the 2013 International Investigative Dermatology Meeting. May 8-11, 2013. Edinburgh, Scotland, United Kingdom | Boca, A; Talamonti, M; Galluzzo, M; Botti, E; Buzoianu, A; Costanzo., A | Intervento a convegno |